HGF and neoplasm: Blood tests conducted on grouped clinical patients showed that serum HGF concentrations in patients with poorly differentiated tumors, high tumor grades, and advanced clinical stages were significantly higher than those in patients with well-differentiated tumors, low tumor grades, and early clinical stages (p < 0.05) (32).